MYREXIS INC innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	United States	11
#2	Australia	10
#3	Canada	8
#4	EPO (European Patent Office)	8
#5	New Zealand	6
#6	WIPO (World Intellectual Property Organization)	6
#7	China	5
#8	Brazil	3
#9	Republic of Korea	2
#10	Mexico	2

#	Technology
#1	Therapeutic chemical compounds
#2	Heterocyclic compounds
#3	Medical preparations
#4	Acyclic or carbocyclic compounds
#5	Organic chemistry methods
#6	Steroids
#7	Climate change adaptation technologies
#8	Analysing materials
#9	Measuring microorganism processes
#10	Peptides

Publication	Filing date	Title
US2013317027A1	2012-12-07	Compounds and therapeutic uses thereof
US2013029942A1	2012-10-04	Compounds and therapeutical uses thereof
CN103929961A	2012-06-20	Compounds and therapeutic uses thereof
CN103732067A	2012-04-12	Compounds,compositions and therapeutic uses thereof
WO2012148550A1	2012-02-24	Prodrugs of therapeutic compounds
AU2011223790A1	2011-03-01	Compounds and therapeutic uses thereof
US2011224240A1	2011-01-11	Methods of treating cancer and related diseases
WO2011056611A1	2010-10-26	Coupled reactions for analysis of nucleotides and their hydrolysis
CN102791697A	2010-10-12	Amino-pyrimidine compounds as inhibitors of TBKL and/or IKK epsilon
US8017780B1	2009-10-09	Therapeutic compounds and uses thereof
AU2009268547A1	2009-07-09	Pharmaceutical compounds as cytotoxic agents and the use thereof
NZ586129A	2008-11-14	Therapeutic compounds and their use in treating diseases and disorders
CA2720989A1	2008-04-10	Methods for treating cancer
AU2008236995A1	2008-04-10	Dosages and methods for the treatment of cancer
CA2720983A1	2008-04-10	Method of treating melanoma
NZ572600A	2007-05-14	6-Amino-purine derivatives for the treatment of cancer and fibrogenetic disorders
US2011076248A1	2002-12-20	Immunizing compositions comprising HIV-1 proviral constructs with an inactive p6 gag TSG101 UEV binding domain capable of producing budding-defective viral particles that remain tethered to the cell surface